NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 16773199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Locally advanced pancreatic cancer.

  2005cited by this paper
• Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.

  2005cited by this paper
• Targeting transcription factors for cancer therapy.

  2005cited by this paper
• Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership.

  2005cited by this paper
• NF-kB in development and progression of human cancer

  2005cited by this paper
• Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin

  2005cited by this paper
• Inflammation-associated cancer: NF-kappaB is the lynchpin.

  2005cited by this paper
• Pancreatic fibrosis associated with age and ductal papillary hyperplasia

  2005cited by this paper
• Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-κB pathway in pancreatic carcinoma cells

  2005cited by this paper
• Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers.

  2005cited by this paper
• New molecular concepts of Barrett's esophagus: clinical implications and biomarkers.

  2005cited by this paper
• Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.

  2005cited by this paper
• Molecular prognostic markers in pancreatic cancer: a systematic review.

  2005cited by this paper
• Ras Oncogene and Inflammation: Partners in Crime

  2005cited by this paper
• Role of Inflammation in Pancreatic Carcinogenesis and the Implications for Future Therapy

  2005cited by this paper
• NF-kappaB: linking inflammation and immunity to cancer development and progression.

  2005cited by this paper
• Activation of transcription factors NF-kappaB and AP-1 and their relations with apoptosis associated-proteins in hepatocellular carcinoma.

  2005cited by this paper
• Molecular markers of early pancreatic cancer.

  2005cited by this paper
• Inflammation and cancer: is the link as simple as we think?

  2005cited by this paper
• Increased expression of NF-kappa B subunits in human pancreatic cancer cells.

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Inflammatory Mechanisms Contributing to Pancreatic Cancer Development

  2004cited by this paper
• Inflammation and necrosis promote tumour growth

  2004cited by this paper
• Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.

  2004cited by this paper
• NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells.

  2004cited by this paper
• The two NF-kappaB activation pathways and their role in innate and adaptive immunity.

  2004cited by this paper
• Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

  2004cited by this paper
• Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.

  2004cited by this paper
• Molecular regulation of pancreatic stellate cell function

  2004cited by this paper
• At the crossroads of inflammation and cancer.

  2004cited by this paper
• NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

  2004cited by this paper
• Nuclear factor‐κB and IκB kinase are constitutively active in human pancreatic cells, and their down‐regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis

  2004cited by this paper
• Fibrosis of the pancreas: the initial tissue damage and the resulting pattern

  2003cited by this paper
• PSK-mediated NF-κB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1

  2003cited by this paper
• A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.

  2003cited by this paper
• To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis.

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas.

  2003cited by this paper
• Apoptosis, inflammatory bowel disease and carcinogenesis: overview of international and Greek experiences.

  2003cited by this paper
• Function of nuclear factor kappaB in pancreatic cancer metastasis.

  2003cited by this paper
• Usage of the NF‐κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer

  2003cited by this paper
• Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.

  2003cited by this paper
• Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancer

  2003cited by this paper
• Cyclin D1 and Molecular Chaperones: Implications for Tumorigenesis

  2003cited by this paper
• Mutations in the v-Rel Transactivation Domain Indicate Altered Phosphorylation and Identify a Subset of NF-κB-Regulated Cell Death Inhibitors Important for v-Rel Transforming Activity

  2003cited by this paper
• Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-κb signaling pathway with the anti-epidermal growth factor antibody IMC-C225

  2003cited by this paper
• Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.

  2002cited by this paper
• Acute experimental pancreatitis and NF-kappaB/Rel activation.

  2002cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Pancreatic cancer biology and genetics

  2002cited by this paper
• The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• NF-kappaB regulation in the immune system.

  2002cited by this paper
• Inflammation and the development of pancreatic cancer.

  2002cited by this paper
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

  2002cited by this paper
• Bradykinin increases IL-8 generation in airway epithelial cells via COX-2-derived prostanoids.

  2002cited by this paper
• Pancreatic stellate cell activation and MMP production in experimental pancreatic fibrosis.

  2002cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Nuclear factor-kappa B and cancer: its role in prevention and therapy.

  2002cited by this paper
• PI-3' kinase and NF-kappaB cross-signaling in human pancreatic cancer cells.

  2001cited by this paper
• Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

  2001cited by this paper
• Differentiation of Chronic Pancreatitis from Pancreatic Cancer: Recent Advances in Molecular Diagnosis

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Infections as a major preventable cause of human cancer

  2000cited by this paper
• The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

  2000cited by this paper
• Aberrant rel/nfkb genes and activity in human cancer

  1999cited by this paper
• NF-kappaB/Rel activation in cerulein pancreatitis.

  1999cited by this paper
• Sulindac inhibits activation of the NF-kappaB pathway.

  1999cited by this paper
• The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

  1999cited by this paper
• Burn scar carcinoma: Diagnosis and Management

  1998cited by this paper
• Landscaping the cancer terrain.

  1998cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• The v‐rel oncogene promotes malignant T‐cell leukemia/lymphoma in transgenic mice.

  1996cited by this paper
• Inhibition of NF-kappa B by sodium salicylate and aspirin.

  1994cited by this paper
• Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.

  1993cited by this paper
• Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells.

  1990cited by this paper
• Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

  1986cited by this paper

• Structural characterization of an apple polysaccharide and its anti-inflammatory effect through suppressing TLR4/NF-κB signaling.

  2025cites this paper
• Advancement in preclinical development of cancer treatment agents through modulation of Rac1: From EHop-016 to natural products.

  2025cites this paper
• Alterations in Signaling Pathways and Therapeutic Strategies of Traditional Chinese Medicine in Granulomatous Lobular Mastitis

  2025cites this paper
• NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer

  2024influential citation
• Updated perspective of EPAS1 and the role in pulmonary hypertension

  2023cites this paper
• Lipopolysaccharide (LPS) stimulation of Pancreatic Ductal Adenocarcinoma (PDAC) and macrophages activates the NLRP3 inflammasome that influences the levels of pro-inflammatory cytokines in a co-culture model

  2023cites this paper
• Anti-inflammatory Mechanism of Action of Benzoylmesaconine in Lipopolysaccharide-Stimulated RAW264.7 Cells

  2022cites this paper
• Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling.

  2022cites this paper
• Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line

  2022cites this paper
• Is autoimmune pancreatitis a risk factor for pancreatic adenocarcinoma?

  2021cites this paper
• Crosstalk between miRNAs and Signaling Pathways Involved in Pancreatic Cancer and Pancreatic Ductal Adenocarcinoma.

  2021cites this paper
• NF-κB and Pancreatic Cancer; Chapter and Verse

  2021cites this paper
• Benzoylaconine Modulates LPS-Induced Responses Through Inhibition of Toll-Like Receptor-Mediated NF-κB and MAPK Signaling in RAW264.7 Cells

  2021cites this paper
• Ameliorative effects of Magnolia sieboldii buds hexane extract on experimental reflux esophagitis

  2020cites this paper
• SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19

  2020cites this paper
• Complexity on modulation of NF‐κB pathways by hepatitis B and C: A double‐edged sword in hepatocarcinogenesis

  2019cites this paper
• Inflammation and Cancer: In Medio Stat Nano.

  2018cites this paper
• Chelidonine inhibits TNF‐α‐induced inflammation by suppressing the NF‐κB pathways in HCT116 cells

  2018cites this paper
• An aqueous extract of Nomura's jellyfish ameliorates inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells and a zebrafish model of inflammation.

  2018cites this paper
• Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine

  2017influential citation
• Design, synthesis and pharmacological analysis of 5-[4′-(substituted-methyl)[1,1′-biphenyl]-2-yl]-1H-tetrazoles

  2017cites this paper
• The role of inflammatory modulators in chronic pancreatitis and the development of pancreatic cancer

  2017cites this paper
• Resveratrol-based cinnamic ester hybrids: synthesis, characterization, and anti-inflammatory activity

  2017cites this paper
• Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward

  2017cites this paper
• Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer–stromal interactions in a mouse xenograft model

  2016cites this paper
• Molecular profiles in foregut oncology.

  2016cites this paper
• Optimization and biological evaluation of aminopyrimidine-based IκB kinase β inhibitors with potent anti-inflammatory effects.

  2016cites this paper
• Combination of 12-O-tetradecanoylphorbol-13-acetate with diethyldithiocarbamate markedly inhibits pancreatic cancer cell growth in 3D culture and in immunodeficient mice

  2015cites this paper
• Chronic Pancreatitis as an Inductor of Pancreatic Cancer — Correlations With Inflammatory Pathways

  2015cites this paper
• Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.

  2015cites this paper
• Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles

  2015cites this paper
• Curcumin and Pancreatic Cancer: A Research and Clinical Update

  2015cites this paper
• [Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer].

  2015cites this paper
• Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NF&kgr;B/STAT3 Inflammatory Signaling

  2015cites this paper
• Interleukin-6: a villain in the drama of pancreatic cancer development and progression.

  2014cites this paper
• Repurposing of Metformin and Aspirin by Targeting AMPK-mTOR and Inflammation for Pancreatic Cancer Prevention and Treatment

  2014cites this paper
• DEPTOR has growth suppression activity against pancreatic cancer cells

  2014influential citation
• Altered Expression of Hypoxia-Inducible Factor-1α (HIF-1α) and Its Regulatory Genes in Gastric Cancer Tissues

  2014cites this paper
• Inflammation, advancing age and nutrition

  2014cites this paper
• Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer

  2013cites this paper
• Efficacy of Dimethylaminoparthenolide and Sulindac in Combination With Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer

  2013cites this paper
• Anti-Pancreatic Cancer Deliverables from Sea: First-Hand Evidence on the Efficacy, Molecular Targets and Mode of Action for Multifarious Polyphenols from Five Different Brown-Algae

  2013cites this paper
• Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice

  2013cites this paper
• The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studies.

  2013cites this paper
• Expression of the adipocytokine resistin and its association with the clinicopathological features and prognosis of pancreatic ductal adenocarcinoma.

  2012cites this paper
• Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents

  2012cites this paper
• Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemopreventive agents.

  2012cites this paper
• The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

  2012cites this paper
• Geniposide Reduces Inflammatory Responses of Oxygen-Glucose Deprived Rat Microglial Cells via Inhibition of the TLR4 Signaling Pathway

  2012cites this paper
• Mycoepoxydiene, a fungal polyketide inhibits MCF-7 cells through simultaneously targeting p53 and NF-κB pathways.

  2012cites this paper
• Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF‐κB signaling pathways

  2012cites this paper
• Aberrant signaling pathways in pancreatic cancer: A two compartment view

  2012cites this paper
• Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

  2012cites this paper
• The Role of Chronic Inflammation: Chronic Pancreatitis as a Risk Factor of Pancreatic Cancer

  2012cites this paper
• Activation of NF-κB Is a Novel Target of KRAS-Induced Endometrial Carcinogenesis

  2011cites this paper
• Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

  2011cites this paper
• Human Cancer Biology Activation of NFk B Is a Novel Target of KRAS-Induced Endometrial Carcinogenesis

  2011cites this paper
• Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer

  2010cites this paper
• Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo.

  2010cites this paper
• Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies

  2010cites this paper
• Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells

  2010cites this paper
• Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

  2010cites this paper
• Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.

  2009cites this paper
• The regulation of constitutive NF-κB activity by glycogen synthase kinase-3 in pancreatic cancer

  2009cites this paper
• TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells.

  2009cites this paper
• Maintenance of Constitutive I κ B Kinase Activity by Glycogen Synthase Kinase-3 α / β in Pancreatic Cancer

  2009cites this paper
• N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression.

  2009cites this paper
• TLR 3-mediated NF-B signaling in human esophageal epithelial cells

  2009cites this paper
• Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.

  2008cites this paper
• NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.

  2008cites this paper
• Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

  2008cites this paper
• New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer.

  2008cites this paper
• Phytochemistry and pharmacology of plants from the ginger family, Zingiberaceae (PhD thesis)

  2008cites this paper
• Calyculin A induces apoptosis and stimulates phosphorylation of p65NF-kappaB in human osteoblastic osteosarcoma MG63 cells.

  2007cites this paper
• Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.

  2007cites this paper
• Cytokine Regulation of the Trefoil Factor Family Binding Protein GKN2 (GDDR/TFIZ1/blottin) in Human Gastrointestinal Epithelial Cells

  2006cites this paper
• [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].

  2006cites this paper